Clinical Trials Browser

Terminated × Ovarian Neoplasms × temsirolimus × Clear all

NCT00926107 2011-11-10

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Phase 2 Terminated

Ovarian Neoplasms